Sound Capital Solutions’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.43M Sell
998,787
-122,021
-11% -$975K 4.83% 7
2026
Q2
$9.8M Buy
+1,120,808
New +$8.48M 2.3% 8

Other funds holding IBRX

Sound Capital Solutions's IBRX Position: Q3 2026 in Review

Sound Capital Solutions reduced its ImmunityBio (IBRX) stake by 11% in Q3 2026, selling an estimated $975K and leaving 998,787 shares worth $9.43M. The position accounts for 4.83% of the portfolio, ranked #7.

Sound Capital Solutions first reported a position in IBRX in Q2 2026 and has held it in 2 quarters since. The position peaked at $9.8M in Q2 2026. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Sound Capital Solutions held 998,787 shares of ImmunityBio worth $9.43M as of Q3 2026.
  • Sound Capital Solutions sold 122,021 ImmunityBio shares in Q3 2026, an estimated $975K.
  • ImmunityBio made up 4.83% of Sound Capital Solutions's portfolio in Q3 2026, its #7 holding.
  • Sound Capital Solutions first reported a position in ImmunityBio in Q2 2026 and has held it in 2 quarters since.
  • Sound Capital Solutions's ImmunityBio position peaked at $9.8M in Q2 2026.
  • 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Sound Capital Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.